Perrigo’s guidance cut should be a concern for investors throughout the generic drug industry.
WSJ.com: Heard on the Street, Wall Street Journal: Markets: Heard on the Street
Mon, 04/25/2016 - 1:33pm
Perrigo’s guidance cut should be a concern for investors throughout the generic drug industry.